Latest receivables for LBPSW: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for LBPSW is $0 as of December 2021. In the prior-year period, the figure was $0. Investors often review this figure alongside 4d Pharma Plc - Warrants (22/02/2025)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, LBPSW's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 4d Pharma Plc - Warrants (22/02/2025)'s operating scale or balance-sheet position.
A receivables figure of $0 for LBPSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting LBPSW's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack 4d Pharma Plc - Warrants (22/02/2025)'s receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.